What's New in Research Funding
Page last updated June 28, 2021
We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:
- All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
- Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the C. David Naylor Building, Suite 119, 6 Queen’s Park Cres W. to the attention of Cindy Faber email@example.com.
- Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact firstname.lastname@example.org..
- Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.
Comprehensive funding opportunities may be searched through these links:
- Pivot Funding Opportunities Database
- U of T Research Funding Opportunities Database (Accessible with a valid UTORid)
- University of Toronto Research & Innovation Awards, Honours & Awards
- Sign up for University of Toronto Research & Innovation "Research Alerts!"
New CRIS Spotlight: Resources for Conducting COVID-19 Research.
The Centre for Research & Innovation Support (CRIS) has published the next issue of Spotlight: Resources for Conducting COVID-19 Research.
This issue includes an up-to-date list of current COVID-19 funding opportunities; a listing of robust sources of published, pre-print, and synthesized research; data sets and visualizations; and more. Visit the CRIS Spotlight page to access these resources.
If you have additional resources to share with the research & innovation community, please notify us at CRIS@utoronto.ca.
To sign up to receive future email communications from CRIS, including new Spotlight resources, please click here.
Recently Recieved News and Updates
June 28, 2021
The Temerty Faculty of Medicine has launched a Ukraine-Toronto Education and Collaboration Initiative, generously supported by the Temerty Foundation’s landmark gift. A new fund has been established to support education and research, with the goal of increasing and deepening our collaborations and partnerships with clinicians, health educators and researchers in Ukraine. Grants are available with the goal of supporting emerging health leaders in Ukraine and the University of Toronto’s Temerty Faculty of Medicine in Canada through collaborative research and educational programs and activities.
Examples of initiatives may include, but are not limited to:
· Collaborative research or educational projects that are co-led by researchers at Temerty Medicine and in Ukraine
· Capacity building trips to Ukraine led by Temerity Medicine faculty member(s)
· Support for Temerty Medicine learners (medical students, clinical trainees, residents, fellows, graduate students) working on projects with demonstrated potential for impact in Ukraine
· Steps to build a network of colleagues interested in a sustained relationship with Ukraine.
Please see the application form for further details.
Maximum Grant: $75,000 CDN (to support up to 2 years maximum)
Deadline for applications: Date: September 30, 2021
Supporting Psychological Health in First Responders is a grant program dedicated to providing or improving services for first responders and emergency health-care workers living with, or at risk of, post-traumatic stress injuries (PTSI). For information on the new cycle of this program, and the application form and completion instructions, please visit: https://alberta.ca/first-responders-mental-health-grants.aspx If you have any additional questions once you have reviewed the posted materials, the program staff can be reached at this email address. SPHIFR@gov.ab.ca. Deadline for submissions: August 3, 2021.
The Translational Biology & Engineering Program (TBEP), at the University of Toronto and the Ted Rogers Centre for Heart Research, in partnership with the Health Innovation Hub (H2i) is pleased to announce a call for applications for the 2021-2022 Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. ECHO is a specialized experiential training program with the main objectives to:
1. Provide entrepreneurship training, mentorship, networking and funding opportunities for early ventures in the cardiovascular health sector.
2. Aid in transferring research innovations and intellectual property from academic and hospital institutions into the economy.
3. Create more start-ups in cardiovascular health sector
Any Canadian-based researcher, clinician, student and/or entrepreneur developing cardiovascular technologies and innovations is eligible to apply. Details can be found here. a. Application: Complete the following two forms and submit by 11:59 p.m. on Friday, August 6, 2021. For full program information and enrolment instructions, please visit the ECHO program page or contact Soror Sharifpoor (Director, Strategy & Translation; TBEP)
A comprehensive view of upcoming award nominations and deadlines.
June 7, 2021
Professor Justin Nodwell, PhD, Vice Dean, Research and Graduate Education
The Centre for Research & Innovation Support: Resources for U of T faculty
Vinita Haroun, Director, Centre for Research & Innovation Support
Prof. Leah Cowen, Associate Vice-President, Research
The Art and Science of grant writing
Professor Tania Watts, PhD, Department of Immunology and University of Toronto CIHR Delegate
10:00am Q&A – 15 minutes
Core Facilities and Services in the Faculty of Medicine
Natasha Christie-Holmes, PhD, Research Operations Officer
Grant Fundamentals and How to Write a Persuasive Research Proposal
Golnaz Farhat, PhD, Grants and Awards Editor
Date: June 23, 2021 from 9am - 11:30am
The University’s Institutional Strategic Initiatives (ISI) are interdisciplinary cross-divisional research networks pursuing grand challenges and bold ideas that require collaboration and the integration of various disciplinary research and training approaches.ISI awards are intended to establish research capacity in high-priority areas, with the goal of realizing transformational impacts on issues of societal importance. These awards are intended to increase the University’s capacity to launch, grow, and sustain strategic research initiatives, thereby increasing the University’s research impact and opportunities for external funding and partnerships.nvestigator-initiated proposals for new initiatives must be championed by multiple Academic Divisions before being considered for ISI funding. Proposed initiatives must meet the following key criteria.
- Address a significant challenge and associated research questions that requires an interdisciplinary approach
- Matching funds secured from three or more Academic Divisions
- Path to sustainability demonstrated by a clear opportunity for external funding
Funding for New Initiatives: from $50,000-$300,000 per year for up to three years. The proposal budget must include cash matching funding from three or more Academic Divisions. In-kind contributions can be used to demonstrate support for the project but will not be matched. Applications are submitted by the vice/associate dean/principals research of an Academic Division. Faculty interested in launching an initiative or supporting an existing initiative should contact the academic leadership team in their division’s research office, such as the Vice Principal or Vice/Associate Dean Research.Full program details and application materials can be found on the ISI website:
Supporting Community Engaged Research at U of T
Professor Ted Sargent, Vice-President, Research & Innovation and Strategic Initiatives, has invited Community Engaged Research (CER) leaders from across the University to engage with their CER faculty colleagues to develop rcommendations for supporting CER at our University. To support this effort Profs. Barbara Fallon, Sherry Fukuzawa, Carmen Logie, Ito Peng, Sali Tagliamonte, and Eve Tuck are hosting a University Forum on June 23rd to listen, share, and learn from CER faculty scholars at U of T and help co-create a roadmap forward.
- University Forum – Identifying Opportunities to Support Community Engaged Research, June 23rd, 2021 1:00 - 3:00 p.m. This session will provide an opportunity for researchers to share their perspectives on how U of T can best support CER scholars at U of T. Registration & Session Details https://cris.eve.utoronto.ca/home/events/1658
- A pre-forum Community Engaged Research Problem Tree session, led by Prof. Eve Tuck, will be hosted on June 15th from 2:00 - 4:00 p.m. to map the challenges of conducting CER at U of T (interest to be indicated on the registration page linked above). Input from these discussions will help to shape both short- and long-term recommendations to the VP, Research & Innovation and Strategic Initiatives for helping our scholars to advance their academic missions and attract support for their research
PSI Graham Farquharson Knowledge Translation Fellowship is intended to provide salary support for a new/mid-career investigator who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research. Please note: Knowledge translation must be the fundamental purpose of this Fellowship and must be demonstrated in the application. The funding guidelines are available on their website at Funding Programs - PSI Foundation. Unlike previous years, PSI will be launching the 2022 competition though a Letter of Intent (LOI) process. Please note that for the 2022 competition, applicants are required to submit their applications directly to PSI, not through the institution. They require all applicants to submit the completed LOI directly to PSI via the PSI Online Grants Management System https://psifoundation.smartsimple.ca/ by July 16th, 2021 5pm EST. LOIs will be reviewed by the PSI Grants Committee in August 2021. PSI will invite successful applicants to submit full applications by November 8th, 2021 5pm EST, which will undergo internal review for a final funding decision in December 2021.
May 12, 2021
The Research and Graduate Education Office will be hosting its inaugural Banting Postdoctoral Fellowship Information Session on How to Write a Successful Banting Postdoctoral Fellowship Application for all UofT Temerty Faculty of Medicine postdoctoral researchers. This year Golnaz Farhat, Grants and Awards Editor, and Dr. Vito Hugo Balasco Serrão, Banting Postdoctural Fellow, will be speaking. Also, opening remarks will be made by Dr. Justin Nodwell, Vice Dean, Research and Graduate Education
For more information about the 2021-22 Banting Postdoctoral program at the Temerty Faculty of Medicine, visit our webpage here.
Registration: visit here!
Please note: Zoom details will be provided a few days before the event.
Date: June 15, 2021 from 12:00pm - 2:00pm
The call for proposals is now open! Mitacs Elevate is now accepting proposal submissions for two years of postdoc funding valued at $60,000/year plus extensive customized professional development training ($7,500/year non-cash value).
- June 2, 2021 — If applicable, deadline to submit not-for-profit eligibility check or conflict of interest declaration at 5 p.m. PT
- June 30, 2021 — Deadline to submit full application at 5 p.m. PT
The Aplastic Anemia and MDS International Foundation, Inc. (AAMDSIF) is pleased to help researchers dedicated to the study of bone marrow disorders, advance the understanding, prevention and treatment of the following bone marrow disorders in both pedriatric and adult populations:Successful applicants can be funded up to $60,000 for two years ($30,000 each year, with second-year funding pending approved progress in the first year).
Deadline for LOIs: June 30, 2021; Application deadline: October 16, 2021.
Their greatest interest is in funding translational and clinical research projects, particularly those projects focused on the neurological problems faced by all patients with A-T. They are desperate to deliver new ideas from A-T research with practical relevance for patients into the hands of experts involved in drug discovery and clinical development. They have interest in disease-modifying strategies that would prevent, slow, or stop the progression of the disease as well as symptom-improving strategies that address neural circuit function, immune system health and lung function. One- and two-year proposals are funded up to a maximum total direct cost of US $75,000 per year. Short-term "bridge funding" may very rarely be provided to investigators who are applying for funding from other sources such as the NIH and need interim support while generating preliminary data necessary for their application. We limit this bridge funding support to a maximum of $50,000 and one year.
Deadline for LOIs: July 1, 2021, Deadline for full applications: September 1, 2021.
May 3, 2021
The TC3 Fellows Program was established to provide financial support for outstanding trainees (MSc, PhD, Postdoc) working on interdisciplinary, collaborative cannabis and cannabinoid-related projects in TC3 member research groups across the University of Toronto and the Toronto Academic Health Sciences Network. Funding Amount: $10,000 (Graduate Students) and $30,000 (Postdoctoral Fellows).
Deadline: May 25, 2021 at noon.
Join us at the TC3 Launch Research & Networking Symposium.
This symposium will bring together cannabis and cannabinoid researchers and trainees from the University of Toronto and Toronto Academic Health Sciences Network and will provide an opportunity to network, seek new collaborations, build links and share health research findings related to cannabis and cannabinoids. Featuring short talks and a panel session, this research and networking symposium will serve as a platform to highlight our local ecosystem's cannabis and cannabinoid research assets from plant all the way to policy and everything in between. Register now.
We are pleased to announce the 2nd round of the Temerty Knowledge Translation Grant Program to fund collaborative projects led by Temerty Medicine faculty members working with community organizations to address health inequities. A total of $250,000 is available in this round to fund 1-year grants of up to $100,000. The competition is open to full-time Temerty Medicine faculty members on campus and at hospital-based research institutes affiliated with the University of Toronto.
Deadline for submission: June 15, 2021.
OBIO’s Business Development Skills Program provides funding to scaling companies of all sizes to increase their business development bench strength. The program supports companies as they build and enhance critical capabilities in-house by providing mentorship and training for key team members. With OBIO’s health science industry support, employers are able to be more successful in securing ‘sticky’ capital from global investors to grow their businesses and create new jobs. OBIO's goal is for health science companies to grow in Ontario, stay in Ontario and be leaders in the global market.
Application deadline: May 28, 2021.
The long standing Navigator Research Program supports HD researchers across Canada. This program supports basic scientific research of direct and immediate relevance to Huntington Disease in Canada with the aim of providing a platform for the recruitment of outstanding investigators to HD research, to facilitate research collaboration nationally and internationally, and to support research that is relevant to other neurodegenerative disorders.
Deadline for LOIs: May 31, 2021, Deadline for invited full applications: July 9, 2021.
April 14, 2021
Online questionnaire for CIHR research community.
Dr. Michael Strong, CIHR President, will engage with representatives of the University of Toronto leadership and research community in a virtual meeting in May. In advance of his virtual visit, we are providing the CIHR research community an opportunity to share their comments on some pressing issues available through a questionnaire that we have posted online for your convenience. You can access and complete the questionnaire at: CIHR May 2021 Questionnaire. We ask that you kindly provide your responses no later than 5 pm on Friday, April 23rd, 2021. After the questionnaire closes, we will review and summarize responses and develop feedback for Dr. Strong. Please contact Drew Gyorke if you have any questions at: email@example.com
This session will feature NIH Program Officer, Dr. Dona Love, to provide insights on NIH funding opportunities and the application and peer-review processes. The session will also welcome a panel of campus - and hospital-based researchers who have demonstrated a history of success with NIH proposals. Panelists will share insights, including the intricacies of the NIH peer review process, and also discuss practical tips and strategies that faculty can engage in to enhance their chances of success.
Date: May 3, 2021, 2:30pm-4:00pm
The goal of the 2021 Research Grant Competition is to fund research that advances Fighting Blindness Canada’s mission to accelerate the development and availability of treatments and cures for blinding eye diseases. The program allows applications from all areas of vision research. The program is open to independent investigators and/or research teams with a principal investigator from a Canadian institution and provides a budget of up to $100,000 a year for up to two years.
Deadline for Letters of Intent: April 29, 2021, Full applications due July 22, 2021.
NSERC and Mitacs are pleased to build on the success of their existing partnership with a new joint initiative that will support the R&D efforts of Canadian university researchers and their partners, while supporting highly qualified personnel including students and/or postdoctoral fellows. Through NSERC’s Alliance grants and Mitacs’s Accelerate, this new opportunity is available to Canadian researchers through a single application submission and review process. Applicants are invited to include in their Alliance application a request for additional support through Mitacs Accelerate internships as a component of the training of highly qualified personnel.
The Human Biology Project was launched in 2013 with the goal of fostering innovative research in collaboration with HD clinics to better understand the biology of Huntington’s disease as it occurs in humans. HDSA encourages researchers to consider one of HDSA’s 54 Centers of Excellence as a potential collaborator, but applicants may propose to work with any HD clinic around the world. Upper amount: $150,000 USD.
Deadline for Letters of Intent: May 7, 2021; Application deadline: July 9, 2021.
March 23, 2021
The focus of this program is to provide early support for exploratory ideas, particularly those with novel hypotheses. Appropriate projects for this mechanism include those considered higher risk but with the potential for transformative results. In particular, they encourage applications that propose research to link genetic or other ASD risk factors to molecular, cellular, circuit or behavioral mechanisms and set the stage for development of novel interventions. Pilot Awards Support innovative, high-risk, proposals requesting support for projects or early-stage experiments. The maximum budget is $300,000USD (including 20% indirect costs) for up to 2 years.
Letter of Intent Deadline: May 6, 2021. Applicants will be notified if they will be invited to full proposal on July 1, 2021.
The National Institutes of Health has released the included requests for applications and program announcements.
US Department of Defense (DOD) Office of the Congressionally Directed Medical Research Programs (CDMRP) has released funding and pre-funding announcements for the following programs:
- Multiple Sclerosis Research Program (MSRP)
- Lupus Research Program (LRP)
- Lung Cancer Research Program (LCRP)
- Peer Reviewed Medical Research Program (PRMRP)
- Gulf War Illness Research Program (GWIRP)
Details on how to apply can be found here.
The purpose of this Young Investigator Grant is to provide an investigator the opportunity to initiate, continue or complete a project that focuses on either basic or clinical management into the causation, epidemiology, molecular biology, cytogenetics, morphology, prognosis and treatment of the Myelodysplastic Syndromes or related myeloid neoplasms. An investigator, US or International, that is 40 years old or less on the date of application submission is eligible. Upper amount: USD $100,000. Funding may be used towards salary support, technician support, supplies, equipment, travel, etc. necessary for the pursuit of the recipient’s research project. The grant period is from July 1, 2021 through June 30, 2023.
Deadline for applications: April 30, 2021.
Action on Hearing Loss (Trading Name of the Royal National Institute for Deaf People ([RNID]). Translational Grant (TRIH Grant).
The Translational Grant aims to support and accelerate the translation of research discoveries into potential new treatments to protect and regenerate hearing and /or silence tinnitus. It funds projects at both academic institutions and small/medium enterprises in any country. It supports:
- research with a strong commercial potential that is likely to attract follow-on funding at the conclusion of the grant
- studies that will facilitate and enable the progression of promising basic research towards testing in clinical trials.
Applicants may be from any country and may be from academic institutions and small/medium enterprises. Grants are up to £100,000 per year, for up to three years. Indirect costs or the salaries of permanent employees will not be funded.
Deadline for Expressions of Interest: April 9, 2021; Application deadline: June 11, 2021.
March 11, 2021
The Simons Foundation Autism Research Initiative is now accepting applications that address foundational knowledge about the neurobehavioral differences associated with autism spectrum disorders (ASD), which will directly inform the development or refinement of tools needed for translational efforts, such as biomarkers and outcome measures. Special emphasis is placed on objective, quantitative measures that may be used in conjunction with standardized clinical measures and genomic information to better triangulate phenotypic and neurobiological variability within and across individuals with ASD. Project budget must be for $750,000 or less, inclusive of 20 percent indirect costs, over a period of up to three (3) year.
UofT Internal deadline: April 29, 2021; Sponsor deadline: May 3, 2021.
CIHR has launched the 2021 IAB membership cycle. Applications submitted online between now and April 12, 2021 will be considered for the 2021 cycle. During the selection process, each Institute will review the full list of candidates who submitted applications to their IAB to determine which candidates best fill the critical gaps created by turnover, both in expertise and in re-balancing demographic criteria (sex, language, career stage, and geographic and institutional representation). There will be a focus on ensuring that the IAB’s reflect the diversity of Canada and the health research ecosystem at large, and underrepresented groups are encouraged to apply to the open call. During this year’s membership cycle, the following Institutes are looking for new members to fill gaps (some gaps have been identified) on their IABs:
The grants are awarded for 2 year for research project to support knowledge generation that will eventually lead to early detection of MS at the individual level multiple sclerosis. The maximum budget is $300,000 USD in direct costs. Town Hall & Q & A Webinar On Wednesday March 17, 2021, Noon EST NMSS will host a Town Hall webinar (register here) where their research staff will describe the intent of the RFA and answer questions. This session will be recorded and posted to the website. For this funding opportunity, a pre-application must be completed and submitted to the Society before the applicant can prepare a full application. Applicants are recommended to submit pre-applications well in advance of the pre-application due date. NMSS will provided notification of approval, disapproval, or the need for changes within two business days of pre-application submission. UofT Internal deadline: April 27, 2021 Full-applications sponsor deadline: April 30, 2021.
The National Institutes of Health has released the included requests for applications and program announcements.
This research symposium with highlight the importance of mitochondrial medicine and introduce new and exciting areas for mitochondrial research.
When: April 8th & 9th
Event Details & Registration | Mitochondrial Innova (mito2i.ca)
Pfizer Global Medical Grants (GMG): Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain.
Through this RFP, their intent is to support virtual and potentially live programs and other innovative digital medical education for HCPs. The focus is on Osteoarthritis and Chronic Pain associated with OA and patient-centered standard of care and management including pain and function, the biopsychosocial aspects of the disease, the complexities and challenges of care, and the future of OA/OA pain management. Programs targeted towards reviewing data at virtual or live osteoarthritis, rheumatology, pain, primary care, or other associated medical conferences, including but not limited to OARSI, EULAR, PAINWeek, AAFP, WCO, and ACR are of particular interest, as well as other meaningful education outside of congresses. The typical grant maximum under this RFP will be up to $200,000 USD. However, larger proposals may be considered for funding if they include a broad geographical scope and multiple activities.
Deadline for applications: March 19 or June 18 or August 20, 2021.
Pfizer Global Medical Grants (GMG): Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease.
Projects that will be considered for Pfizer support will focus on preparing and/or optimizing multidisciplinary care teams for the integration of gene therapy into the treatment armamentarium for patients with a Rare Disease. Support is available for the development of leadership, best practices, SOP development, site readiness, support and/or training of HCPs within a multidisciplinary team environment to optimize the quality of care for patients who have/will have gene therapy in their treatment armamentarium. Projects that address recombinant adeno-associated virus gene therapy in Rare Disease and are therapeutic area and disease area agnostic (i.e., platform) will be prioritized. Amount: Up to USD $50,000.
Deadline for applications: June 1, 2021.
The intent of the Clinical Pilot and Feasibility Award is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger scale research and/or multi-center, collaborative clinical trial. Support may be requested for USD $80,000 annually (plus 12 percent for indirect costs) for up to two years.
Deadline for Letters of Intent: March 19, 2021; Full application deadline: August 18, 2021.
March 1, 2021
Internal Audit - Understanding Research Expenditure Compliance.
Wednesday, March 10, 2021, 10:00am-11:00am
- Jeff McIlravey, Manager, Internal Audit
- Lusine Amirkhanyan, Senior Auditor, Internal Audit
*Please note - The registration system is not compatible with Internet Explorer. Please use Chrome, Safari, Firefox, or MS Edge to register
CIHR will be hosting the following webinar to support participants with the requirements of the funding opportunity “Health Research Training Platform (HRTP) Pilot - Information for Applicants” and to answer questions on how to apply.
When: Thursday, March 4, 2021 at 13:00 pm ET
Language: English presentation followed by a period of questions and answers in both official languages, English and French
Duration: 90 minutes |. Join
Below is a list of upcoming award nomination deadlines. Please contact Golnaz Farhat if you are interested in nominating for these awards:
- March 31, 2021 - RSC McLaughlin Medal) – Program Homepage
- April 2, 2021 - Lucian Award for Research in Circulatory Diseases – Program Homepage
- May 7, 2021 - Paul Marks Prize for Cancer Research – Program Homepage
- June 1, 2021 - Henry G. Friesen International Prize in Health Research – Program Homepage
- June 30, 2021 BBVA Foundation Frontiers of Knowledge Awards in Biology and Biomedicine – Program Homepage
Pediatric Infectious Diseases Society (PIDS) Pichichero Family Foundation Research Development, Vaccines for Children Initiative Award in Pediatric Infectious Diseases.
The award is intended to support translational and clinical research involving vaccine development and/or pathogenesis or host-pathogen interaction moves the field towards the development of new vaccines and therapeutics. Studies of new uses of existing vaccines (e.g., use in a special population) may also be considered; however, preference will be made for studies that advance new knowledge, new insights into vaccine and immunotherapeutic development, pathogenesis and host-pathogen interactions. Research proposals that focus principally on disease surveillance or vaccine attitudes/hesitancy are unlikely to be funded. The Research Award provides USD $50,000 in total costs (inclusive of 8% indirect costs) per year for up to 2 years. Deadline for applications: July 15, 2021.
Angelman Syndrome Foundation, Inc. (ASF) Special Call for Research to Address Gastrointestinal Complications.
The ASF Scientific Advisory Committee identified the following areas of unmet need in AS research. Priority will be given to the following topics:
- Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.
- Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.
- Projects studying delivery of therapies and potential for improvement.
- Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.
Proposals that do not address these topics are still welcome and will be given full consideration. Award Amount: up to USD $100,000. Deadline for applications: March 15, 2021.
The Senior Research Awards objective is to provide established researchers with funds to generate sufficient preliminary data to become competitive for funds from other sources such as the National Institutes of Health (NIH). Proposal must be relevant to Inflammatory Bowel Disease (IBD) or Crohn's disease and/or ulcerative colitis.Total maximum award per year: USD $115,830 (subject to annual progress report approval). Duration: One to three years.
Deadline for LOIs: May 5, 2021; Deadline for full proposals: July 20, 2021.
February 11, 2021
Registration for the Spring 2021 CIHR Project Grant competition opened on February 4, 2021. Registration is due to CIHR by March 4, 2021 and full applications due to CIHR by April 1, 2021. Please find a detailed message from CIHR regarding some changes to the Spring 2021 Project Grant competition. Changes include: Revised Summary of Progress, Removal of Weighted Scores, Use of the Applicant Profile CV for Knowledge Users, Indigenous applicants and International applicants, and ensuring equitable access to research funds.
CIHR has announced the launch of the new Reviewer in Training (RiT) program for the Spring 2021 Project Grant competition. The RiT program expands on and replaces the Observer program to offer Early Career Researchers (ECRs) a learning opportunity to gain a better understanding of the elements of high quality review and the peer review process through direct participation in the Project Grant competition with the support of a Mentor. Applications to the RiT program may be submitted directly to CIHR prior to the application deadline. Full details including the link to apply online can be found here.
Application deadline: February 26, 2021.
CIHR would like to provide the research community with information about the upcoming launch of a rapid research response, comprised of three separate but linked initiatives, designed to contribute to global efforts to address SARS-CoV-2 variants.
- Initiative 1: Supplementary funding for CIHR funded COVID-19 researchers studying variants
- Initiative 2: Priority funding of applications focusing on SARS-CoV-2 variants
- Initiative 3: Funding of a Canadian Network of Networks for SARS-CoV-2 Variant Research
Pre-announcement Informational Page: Web page with further information on the three initiatives, funding amounts and eligibility details.
2021-23 Joint EMHSeed And XSeed Call For Proposals: Expanding research impact through inter-disciplinary collaboration.
The Joint EMHSeed and XSeed is an interdivisional research funding program designed to promote multi-disciplinary research and catalyze new innovative partnerships between a coPI from the Faculty of Applied Science and Engineering (FASE) and a coPI from outside Engineering. Partner divisions for these programs are:
- For EMHSeed: Temerty Faculty of Medicine (FoM), UofT Affiliated Hospitals, Medicine by Design (MbD), Translational Biology and Engineering Program (TBEP)
- For XSeed: Faculty of Arts and Science (FAS), University of Toronto Mississauga (UTM), University of Toronto Scarborough (UTSC), Dalla Lana School of Public Health (DLSPH), as well as other UofT Divisions.Funding is available for a maximum of fifteen (15) new collaborative projects beginning in early September 2020. The budget for each Seed project will be $60,000 CAD/year for two (2) years. In exceptional cases, a no-cost extension for an additional year will be considered.
The deadline for documentation is March 31, 2021 at 12:00 noon.
MITO2i Together With Its Partners Funds Innovative Projects Accelerating the Field of Mitochondrial Research.
MITO2i is pleased to announce that 5 Innovation Grants, 2 Post-Doctoral Fellowships and 6 Graduate Student Scholarships will be awarded the funding.
The intent of this Request for Proposal (RFP) is to support basic science, pre-clinical research and clinical research through a competitive grants program that advances medical knowledge of the role of ANGPTL3 in health and disease.0.Individual projects requesting up to USD $250,000 will be considered. Pfizer anticipates a total fund of USD $750,000. Research is expected to be completed and submitted for presentation/ publication within 3 years of
Deadline for Letters of Intent: March 12, 2021; Full proposals due: July 2, 2021.
The IETF is requesting proposals for grants addressing the nosology, etiology, pathogenesis, treatment or other topics relevant to essential tremor (ET). In general, each IETF research grant will not exceed $50,000 each for a given year. Institutional indirect costs will not be provided.
Deadline for applications: February 28, 2021.
January 28, 2021
NSERC’s Collaborative Research and Training Experience (CREATE) program awards grants of up to $1.65M over 6 years for the development of innovative training programs designed to enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce. In preparation for the next CREATE competition, NSERC will hold an information session via Cisco Webex webinar to provide an overview of the CREATE program and application process. The dates of the sessions are as follows:
English session: February 4th 2021, 1:30 p.m. to 3:30 p.m. (ET)
French session: February 5th 2021, 1:30 p.m. to 3:30 p.m. (ET)
Registration is not necessary – anyone can connect using the link provided below.
CIHR will be hosting “Ask Me Anything” sessions designed to support participants and answer questions about the Spring 2021 Project Grant competition. Questions will be accepted via a Slido question board.
Duration: 90 minutes
When: Thursday, February 4, 2021 at 15:00 pm ET
When: Friday, February 5, 2021 at 13:00 pm ET
When: Wednesday, February 3, 2021 at 11:00 am ET -
New Investigator Grants provide important early career development support to child health researchers. The competition is open to early career investigators from any CIHR eligible institution, who may apply for up to 3 years' support for research in biomedical, clinical, health systems and services, population and public health sectors. Another key support for these investigators has been CIHR’s decision to temporarily "pause the clock” for early career researchers, extending eligibility for one additional year, which also applies to this partnered competition. The maximum amount for a single grant is $300,000 ($100,000 per year for up to 3 years). Deadline for applications: April 20, 2021.
The National Institutes of Health has released these requests for applications and program announcements.
The Human Frontier Science Program (HFSP) supports innovative basic research that applies novel and interdisciplinary approaches to understand fundamental biological problems and includes scientific exchanges across national and disciplinary boundaries. Grants are for 3 years and made to international teams of 2 – 4 members who have not collaborated before. The amount is dependent upon team size, up to $465,000 per year for a team of four.
UofT internal deadline: March 26, 2021: HFSP deadline for LOIs: March 30, 2021.
CAAIF Research Fellowship in Type 2 Inflammation supported by Sanofi Genzyme Canada, Duration: One Year: Amount: $75,000.
Asthma Canada/CAAIF Graduate Student Awards. Duration: One year: Amount: $20,000.
Deadline for submissions: April 26, 2021.
January 12, 2021
Temerty Knowledge Translation Grant development of novel antibody tools for COVID-19 diagnosis or immunotherapies.
These grants are designed to support our researchers in translating fundamental science towards impactful applications in collaboration with a knowledge translation partner.
Value: three thresholds of $25,000, $50,000, and $100,000 per award
Duration: 1 year, with the possibility of an additional 1-year no-cost extension
Application deadline: February 15th
Eligibility: all Temerty Medicine faculty members can apply. A KT partner (e.g. clinical collaborator, industrial partner) must also be included.
Application form for further details and submission process.
Please note that this is the first in a series of Temerty Knowledge Translation Grants. Future calls will be open to any KT-oriented projects or focused on other emerging priority areas.
T-CAIREM has announced two new programs to introduce U of T undergraduate and medical students to the field of AI in healthcare. T-CAIREM at the University of Toronto is an interdepartmental Centre that serves as a focal point for collaboration between computer scientists, healthcare providers, trainees, medical basic science researchers and industry to advance health through machine learning.
- T-CAIREM 2021 Student Trainee Rounds
Deadlines for Submissions: February 1, 2021
- T-CAIREM 2021 Summer Research Studentship
Application deadline: 5pm February 19, 2021
The Annual STrengthening Administration of Research (STAR) Conference has been transformed into a series of online workshops that will be held over the course of 2021.
Join your peers in expanding your knowledge on preparing for audits, the new procurement thresholds, research service vs. collaboration agreements, administering Canada Foundation for Innovation funds, the Tri-Agency Guide on Financial Administration, and more!
Workshop #1 - Research Administration Processes: The Impact of COVID-19
Thursday, January 28, 2021, 10:30-11:30am (Registration for Star Workshop #1)
Donna Walker, Director, Research Financial Reporting & Audit, Research Oversight & Compliance, VPRI
Drew Gyorke, Director, Agency and Foundation Funding, Research Services VPRI
Kevin Hamilton, Director, Institutional Initiatives, Research Services, VPRI
Workshop #2 - Research Procurement Updates
Wednesday, Feb. 17, 2021 10:30 am – 11:30 am
Presented by Nathan King, Senior Procurement Officer, Procurement Services
(Register now for STAR workshop #2)
To kick start the New Year MITO2i is pleased to invite graduate students and post-doctoral working in all areas of mitochondrial research to participate in our fun and educational Science Communication Workshop and Video Competition. This exciting event will give trainees the chance to learn more about knowledge dissemination and how to effectively share their research to the general public. We are thrilled to announce that Ivan Semeniuk, Science Journalist for The Globe and Mail and who has previously worked for Nature, New Scientist Magazine and the Discovery Channel will be joining MITO2i on January 27th to host a workshop for trainees on science communication. This will be followed by a video tutorial workshop. More information on both workshops can be found below.Trainees will then have the opportunity to create there own 1 minute video describing their research in a fun and engaging way. Prizes will be awarded for the most innovative videos.To register for both workshops please click the links below:
MitoFUTURES Workshop Series- Science Communication | Mitochondrial Innova (mito2i.ca)
MitoFUTURES Workshop Series- Video Tutorial | Mitochondrial Innova (mito2i.ca)